Liao D F, Duff J L, Daum G, Pelech S L, Berk B C
Department of Medicine, University of Washington, Seattle 98195-7710, USA.
Circ Res. 1996 Nov;79(5):1007-14. doi: 10.1161/01.res.79.5.1007.
Both angiotensin II (Ang II) and platelet-derived growth factor (PDGF) rapidly increase intracellular Ca2+ and activate protein kinase C (PKC) and MAP kinase in vascular smooth muscle cells (VSMCs). However, Ang II causes cell hypertrophy, whereas PDGF causes hyperplasia. These findings indicate that VSMCs are a good model for studying the relationship between cell growth and the MAP kinase pathway. In this study, we investigated the role of Raf in activation of 42- and 44-kD MAP kinases. Western blot analysis showed that c-Raf-1 was the predominant Raf isozyme in cultured rat aortic VSMCs. In response to Ang II, there was translocation of Raf to the membrane, which occurred significantly earlier than MAP kinase activation, suggesting that Raf activation precedes MAP kinase activation. Translocation of Raf to the membrane resulted in association with H-Ras as shown by c-Raf-1 coprecipitation with anti-Ras anti-bodies. Western blot analysis of H-Ras immunoprecipitates revealed c-Raf-1, but c-mos, MEK (MAP kinase/extracellular signal-regulated kinase) kinase-1 (MEKK-1), and Raf-B were not present. MAP kinase kinase kinase (MAPKKK) activity was assayed in c-Raf-1 and H-Ras immunoprecipitates by MAP kinase kinase-dependent phosphorylation of catalytically inactive 42-kD MAP kinase. In Ras immunoprecipitates, MAPKKK activity was stimulated approximately threefold by both Ang II and PDGF, with a peak at 5 minutes. Downregulation of PKC by 24-hour exposure to phorbol ester significantly inhibited Ang II-stimulated and PDGF-stimulated MAPKKK activity (approximately 80% decrease) and Raf translocation (approximately 90% decrease), suggesting that a phorbol-responsive PKC is upstream from MAPKKK and Raf. In contrast, Ang II (but not PDGF) stimulation of MAP kinase was unaffected by PKC downregulation or pharmacological PKC inhibition. These findings demonstrate for the first time that Ang II stimulation of MAP kinase may occur via a pathway independent of c-Raf-1 and of the phorbol-responsive PKC isozymes. The differing effects of Ang II and PDGF on VSMC growth may be a consequence of specific signal transduction events, as demonstrated here for activation of MAP kinase.
血管紧张素II(Ang II)和血小板衍生生长因子(PDGF)均可迅速增加血管平滑肌细胞(VSMC)内的Ca2+浓度,并激活蛋白激酶C(PKC)和丝裂原活化蛋白激酶(MAP激酶)。然而,Ang II可导致细胞肥大,而PDGF则导致细胞增生。这些发现表明,VSMC是研究细胞生长与MAP激酶信号通路之间关系的良好模型。在本研究中,我们调查了Raf在42-kD和44-kD MAP激酶激活中的作用。蛋白质印迹分析显示,c-Raf-1是培养的大鼠主动脉VSMC中主要的Raf同工酶。在Ang II刺激下,Raf会转位至细胞膜,这一过程明显早于MAP激酶的激活,表明Raf的激活先于MAP激酶的激活。Raf转位至细胞膜导致其与H-Ras结合,如用抗Ras抗体进行的c-Raf-1共沉淀所示。对H-Ras免疫沉淀物进行蛋白质印迹分析发现存在c-Raf-1,但不存在c-mos、MEK(MAP激酶/细胞外信号调节激酶)激酶-1(MEKK-1)和Raf-B。通过对无催化活性的42-kD MAP激酶进行依赖于MAP激酶激酶的磷酸化反应,在c-Raf-1和H-Ras免疫沉淀物中检测MAP激酶激酶激酶(MAPKKK)活性。在Ras免疫沉淀物中,Ang II和PDGF均可使MAPKKK活性增加约3倍,在5分钟时达到峰值。通过24小时暴露于佛波酯下调PKC可显著抑制Ang II刺激和PDGF刺激的MAPKKK活性(约降低80%)以及Raf转位(约降低90%),表明一种对佛波酯有反应的PKC位于MAPKKK和Raf的上游。相反,PKC下调或药理学上的PKC抑制对Ang II(而非PDGF)刺激的MAP激酶没有影响。这些发现首次证明,Ang II刺激MAP激酶可能通过一条独立于c-Raf-1和对佛波酯有反应的PKC同工酶的信号通路发生。Ang II和PDGF对VSMC生长的不同影响可能是特定信号转导事件的结果,如此处所示的MAP激酶激活。